AbbVie Acquires Nimble Therapeutics in $200M Deal to Strengthen Immunology Pipeline AbbVie has announced its acquisition of Nimble Therapeutics for $200 million upfront, marking another significant move in the pharma giant's strategic efforts to bolster its long-term growth prospects...

www.linkedin.com/pulse/abbvie...

AbbVie Acquires Nimble Therapeutics in $200M Deal to Strengthen Immunology Pipeline

kstrategyand.com/pharma-news

#AbbVie #NimbleTherapeutics #Immunology #AutoimmuneDiseases #Skyrizi #Rinvoq #InflammatoryBowelDiseases #Neuroscience#Humanteconomy #Humantec